2018•Journal of clinical lipidologyRequires access

Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics

Marie‐Soleil Gauthier, Zuhier Awan, Annie Bouchard, Josée Champagne, Sylvain Tessier, Denis Faubert, Katherine Chabot, Pierre Y. Garneau, Rémi Rabasa‐Lhoret, Nabil G. Seidah, Paul M. Ridker, Jacques Genest, Benoit Coulombe

Open publisher page 12 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Kexin, Proprotein convertase, Subtilisin, Medicine, PCSK9, Proteomics, Bioinformatics, Computational biology